Liver Disease
Conference Coverage
NAFLD can regress with weight loss, activity
BOSTON – All phenotypes of nonalcoholic fatty liver disease can progress or regress even without pharmacologic intervention, according to a...
Conference Coverage
Tumor boards linked to improved survival in hepatocellular carcinoma
BOSTON – Veterans were about 13% less likely to die within 5 years of hepatocellular carcinoma diagnosis when multidisciplinary tumor boards...
Conference Coverage
Direct-acting antiretrovirals in genotype 1 HCV patients with mental health conditions safe, well tolerated
Clinicians can feel confident treating genotype 1 hepatitis C virus patients with comorbid psychiatric conditions using direct-acting...
Conference Coverage
VIDEO: PBC patients with compensated cirrhosis fare well on obeticholic acid
BOSTON - Patients with primary biliary cholangitis who have compensated cirrhosis fared just as well on obeticholic acid as did primary biliary...
Conference Coverage
SNP predicts liver cancer in hepatitis C patients regardless of SVR
BOSTON
Conference Coverage
Treatment withdrawal without prior liver biopsy found safe in well-controlled autoimmune hepatitis
Liver biopsy prior to treatment withdrawal in patients with well-controlled autoimmune hepatitis may be unnecessary, contrary to current...
Conference Coverage
Medicaid restrictions loosening on access to HCV therapies
BOSTON – Some state Medicaid directors have started to drop or loosen restrictions on access to direct-acting antiviral treatments for the...
Conference Coverage
VIDEO: Don’t be surprised by weight gain in men after HCV cure
BOSTON
Conference Coverage
Study eyed zinc for slowing progression of chronic liver disease
BOSTON - Oral zinc supplementation was associated with maintenance of liver function and suppression of hepatocellular carcinoma in a...
Conference Coverage
VIDEO: Obeticholic acid resulted in reduction of a biomarker for liver fibrosis in PBC
BOSTON – Obeticholic acid resulted in a significant reduction of a biomarker for liver fibrosis in patients with primary biliary cholangitis,...